Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Belharra Therapeutics Inks $130M in Funding

2023-01-04
SAN DIEGO, CA, Belharra Therapeutics, announced it has secured $130 million in capital, including $50 million in Series A financing.
Belharra Therapeutics, Inc. emerged from stealth mode with a novel photoaffinity-based chemoproteomics platform capable of identifying non-covalent, small molecule drug candidates for any protein. The company has secured $130 million in capital, including $50 million in Series A financing from founding investor Versant Ventures and a multi-year collaboration with Genentech, a member of the Roche Group, that will provide $80 million in upfront capital, also announced today. Belharra is the most recent company to emerge from Versant's Inception Discovery Engine.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors